EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation

Saori Miura, Koki Ueda, Keiji Minakawa, Kenneth E Nollet, Kazuhiko Ikeda iD

Cells · 06.06.2024 · 13 (11) · 993

DOI: 10.3390/cells13110993 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 06.06.2024. Verfasst von Saori Miura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, Fukushima Medical University School of Health Sciences, Fukushima 960-8516, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Transplantation, Homologous, Chimerism. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimerism analysis after allogeneic hematopoietic stem cell transplantation serves to confirm engraftment, indicate relapse of hematologic malignancy, and attribute graft failure to either immune rejection or poor graft function. Short tandem repeat PCR (STR-PCR) is the prevailing method, followed by quantitative real-time PCR (qPCR), with detection limits of 1–5% and 0.1%, respectively. Chimerism assays using digital PCR or next-generation sequencing, both of which are more sensitive than STR-PCR, are increasingly used. Stable mixed chimerism is usually not associated with poor outcomes in non-malignant diseases, but recipient chimerism may foretell relapse of hematologic malignancies, so higher detection sensitivity may be beneficial in such cases. Thus, the need for and the type of intervention, e.g., immunosuppression regimen, donor lymphocyte infusion, and/or salvage second transplantation, should be guided by donor chimerism in the context of the feature and/or residual malignant cells of the disease to be treated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationTransplantation, HomologousChimerismHumansTransplantation ChimeraHematologic Neoplasms

Stichwörter der Autor:innen

chimerism analysishematopoietic stem cell transplantationmixed chimerism

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, Fukushima Medical University School of Health Sciences, Fukushima 960-8516, Japan.
  • Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.

ORCID-Profile: Kazuhiko Ikeda

Zitieren

APA

Miura, S., Ueda, K., Minakawa, K., Nollet, K. E., & Ikeda, K. (2024). Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation. Cells, 13(11), 993. https://doi.org/10.3390/cells13110993

Vancouver

Miura S, Ueda K, Minakawa K, Nollet KE, Ikeda K. Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation. Cells. 2024;13(11):993. doi:10.3390/cells13110993

BibTeX
@article{Miura2024,
  author = {Miura, Saori and Ueda, Koki and Minakawa, Keiji and Nollet, Kenneth E and Ikeda, Kazuhiko},
  title = {Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {993},
  doi = {10.3390/cells13110993}
}
Kostenlos starten →